MIME-Version: 1.0
Content-Location: file:///C:/8F3B5738/b2720533370a4f91a51aa4a8bcf25488.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="utf-8"

<html xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<meta name=3DProgId content=3DOneNote.File>
<meta name=3DGenerator content=3D"Microsoft OneNote 15">
<link id=3DMain-File rel=3DMain-File href=3Db2720533370a4f91a51aa4a8bcf25488.htm>
<link rel=3DFile-List href=3D"b2720533370a4f91a51aa4a8bcf25488.files/filelist.xml">
</head>

<body lang=3Dzh-TW style=3D'font-family:Calibri;font-size:11.0pt'>

<div style=3D'direction:ltr;border-width:100%'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:0in;width:8.8409in'>

<div style=3D'direction:ltr;margin-top:0in;margin-left:.075in;width:1.9409in'>

<p style=3D'margin:0in;font-family:"Microsoft JhengHei Light";font-size:20.0pt'>子宮內膜癌</p>

</div>

<div style=3D'direction:ltr;margin-top:.0388in;margin-left:.075in;width:1.9597in'>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:10.0pt;color:#666666'>2025年2月11日</p>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:10.0pt;color:#666666'>下午
03:46</p>

</div>

<div style=3D'direction:ltr;margin-top:.3888in;margin-left:0in;width:8.8409in'>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:#1F497D'><span
style=3D'font-weight:bold'>概述：與子宮內膜增生高度相關，可一起研讀</span></p>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:#1F497D'>&nbsp;</p>

<h2 style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt;color:black'>流行病學（Epidemiology）</h2>

<ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style=3D'font-family:PMingLiU;font-size:11.0pt'>最常見的女性生殖道癌症（Most common
     gynecologic malignancy）之一</span></li>
</ul>

<ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-family:PMingLiU;font-size:11.0pt'>國考常考重點：婦科三癌（內膜、子宮頸、卵巢癌）</span></li>
</ul>

<ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style=3D'font-family:PMingLiU;font-size:11.0pt'>好發於停經後婦女（Postmenopausal
     women, 平均60-70 歲多）</span></li>
</ul>

<ul type=3Dsquare style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt'>&lt;50 歲與
     PCOS、HNPCC、FH、BRCA、TP53 相關</span></li>
</ul>

<ul type=3Dcircle style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#E36C09'><span
     style=3D'font-family:PMingLiU;font-size:11.0pt'>肥胖、高雌激素狀態為主要危險因子</span></li>
</ul>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt'><span
style=3D'color:black'>危險因子（Risk Factors）：</span><span style=3D'color:red'>Unopposed
Estrogen為主要原因</span></p>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>類別</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.2048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>具體危險因子</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.95in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>內生性（Endogenous E2）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.1854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'><span
  style=3D'color:black'>- </span><span style=3D'font-weight:bold;color:black'>肥胖（Aromatization
  of androgens in adipose tissue）</span><br>
    - <span style=3D'font-weight:bold;color:black'>多囊卵巢症候群（PCOS）</span><br>
    - <span style=3D'font-weight:bold;color:black'>雌激素分泌腫瘤（如顆粒細胞瘤 granulosa cell
  tumor）</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:red'><span
  style=3D'font-weight:bold'>外生性（Exogenous E2）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.2743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'><span
  style=3D'color:red'>- </span><span style=3D'font-weight:bold;color:red'>未合併
  Progesterone 的 HRT（Hormone Replacement Therapy）</span><br>
    <span style=3D'color:red'>- </span><span style=3D'font-weight:bold;color:red'>Tamoxifen（SERM，對內膜具
  Partial Estrogenic Effect）</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>基因相關</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.2048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>- <span
  style=3D'font-weight:bold'>Lynch Syndrome（HNPCC）→ 增加 Type II 風險</span></p>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>- BRCA、TP53</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>代謝疾病</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.2048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>- <span
  style=3D'font-weight:bold'>糖尿病（DM）、高血壓（HTN）、代謝症候群</span></p>
  </td>
 </tr>
</table>

</div>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#E36C09'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:#E36C09'>注意</span><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>：外生性的常考在乳癌、子宮內膜癌</span></li>
</ul>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>

<h2 style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:#1F497D'><span
style=3D'font-weight:bold'>臨床表現（Clinical Presentation）</span></h2>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#E36C09'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt'>最常見症狀：
     停經後異常陰道出血（Postmenopausal bleeding）</span></li>
</ul>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>其他表現：</span></li>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>月經異常（Irregular
      menstruation）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>骨盆疼痛（Pelvic
      pain）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>晚期可能有</span><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>體重減輕（Cachexia）、腹水（Ascites）</span></li>
 </ul>
</ul>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:black'>病理分類（Histological
Classification, WHO 2014）</p>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>類型</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>特徵</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>癌變機轉</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>預後</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Type I（Estrogen-dependent）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>75-80%</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>與長期雌激素暴露相關，常見於肥胖者</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>較佳（低度惡性）</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Type II（Non-estrogen-dependent）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>10-20%</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>常見於年長女性，與 p53 突變相關</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.5576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>較差（高度侵襲性）</span></p>
  </td>
 </tr>
</table>

</div>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt;color:black'>&nbsp;</h3>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt;color:black'><span
style=3D'font-weight:bold'>子宮內膜癌常見病理亞型</span></h3>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>病理類型</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.85in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>所屬類型</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>特徵</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.1138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Endometrioid Adenocarcinoma</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Type I</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>最常見（75-80%）</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Serous Carcinoma</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Type II</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>高度侵襲性，與
  <span style=3D'font-weight:bold'>p53 突變</span> 相關</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Clear Cell Carcinoma</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Type II</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>預後差，細胞異型明顯</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Mixed Carcinoma</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Type II</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.4347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>具兩種以上類型，常見於高齡患者</p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:black'>&nbsp;</p>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt;color:red'><span
style=3D'font-weight:bold'>補充：Type I v.s. Type II爆愛考</span></h3>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>比較特性</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>Type I</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>Type II</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>流行病學（Epidemiology）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>較常見，發生於停經前（年紀較輕）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>發生於停經後（年紀較大）</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:red'><span
  style=3D'font-weight:bold'>雌激素風險（Estrogen Risk）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>非對抗性雌激素（Unopposed
  estrogen）+ 肥胖</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>相關性較低</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>前驅病灶（Precursor Lesion）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮內膜增生（Endometrial
  hyperplasia）→ <span style=3D'font-weight:bold'>非典型增生（Atypical hyperplasia）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.5368in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮內膜萎縮（Endometrial
  atrophy）→ <span style=3D'font-weight:bold'>子宮內膜上皮內癌（Endometrial intraepithelial
  carcinoma）</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>病理型態原型（Histologic Type）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Endometrioid</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Serous</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>其他病理型態（Other Variants）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>黏液型（Mucinous）、具鱗狀分化的內膜樣癌（Endometrioid
  with squamous differentiation）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>部分可見<span
  style=3D'font-weight:bold'>透明細胞癌（Clear Cell）</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>腫瘤分級（Tumor Grade）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>低度（Low
  Grade）</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>高度（High
  Grade）</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>基因變異（Genetic Mutations）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'><span
  style=3D'color:black'>- </span><span style=3D'font-weight:bold;color:black'>PTEN、PIK3CA
  突變</span><br>
    - <span style=3D'font-weight:bold;color:black'>微衛星不穩定性（Microsatellite
  instability）</span><br>
    - <span style=3D'font-weight:bold;color:black'>KRAS 突變</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.4736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'><span
  style=3D'color:black'>- </span><span style=3D'font-weight:bold;color:#E36C09'>P53
  突變（約 90% Type II 具此變異）</span><br>
    - <span style=3D'font-weight:bold'>部分可見 HER-2/neu、CMYC 過量表現</span></p>
  </td>
 </tr>
</table>

</div>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:12.0pt;color:black'>&nbsp;</h3>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt;color:black'><span
style=3D'font-weight:bold'>預後與併發症（Prognosis &amp; Associated Cancers）</span></h3>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.6104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>類別</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>Type I</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>Type II</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.6104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>預後（Prognosis）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:red;
  text-align:center'><span style=3D'font-weight:bold'>較好</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:red;
  text-align:center'><span style=3D'font-weight:bold'>較差</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.6104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>常見合併症（Associated Cancers）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>卵巢癌（Ovarian cancer）</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>乳癌（Breast cancer）、大腸直腸癌（Colorectal
  cancer）、SEOC（Serous Endometrial Ovarian Cancer）</span></p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:black'>&nbsp;</p>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:#1F497D'>診斷（Diagnosis）：與子宮內膜增生相同</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:red'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt'>子宮內膜取樣（Endometrial
     Biopsy, EMB）</span><span style=3D'font-family:PMingLiU;font-size:11.0pt'>：</span><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt'>首選診斷方式</span></li>
</ul>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>影像學：</span></li>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>超音波（Transvaginal
     Ultrasound, TVUS）</span></li>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#E36C09'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt'>停經後內膜
      &gt;4mm → 需進一步檢查</span></li>
 </ul>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>內膜不均勻增厚、異常回聲</span><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'> → 需活檢確診</span></li>
 </ul>
</ul>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle;color:#E36C09'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮鏡（Hysteroscopy）</span><span
     style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>：可發現病變，</span><span
     style=3D'font-family:PMingLiU;font-size:11.0pt;color:#E36C09'>但需切片確診</span></li>
</ul>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:#E36C09'>&nbsp;</p>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:14.0pt;color:black'><span
style=3D'font-weight:bold'>子宮內膜癌 FIGO 分期（FIGO Staging for Endometrial Carcinoma）</span></h3>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>FIGO Stage</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>侵犯程度</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>I</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IA</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮內膜或子宮肌層
  &lt;1/2</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IB</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮肌層
  &gt;1/2</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>II</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮頸基質</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>III</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IIIA</span></p>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>子宮漿膜層（serosa）
  ± 子宮附件（adnexa）</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IIIB</span></p>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>陰道或子宮旁組織</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IIIC</span></p>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IIIC1：</span>骨盆腔淋巴結</p>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IIIC2：</span>主動脈旁淋巴結</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IV</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IVA</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>膀胱或直腸黏膜層</p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.927in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>IVB</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.9187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>遠端轉移（肺、肝、骨頭等）</p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'>&nbsp;</p>

<h2 style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:#1F497D'>治療（Management）</h2>

<h3 style=3D'margin:0in;font-family:PMingLiU;font-size:12.0pt;color:black'><span
style=3D'font-weight:bold'>標準治療</span></h3>

<div style=3D'direction:ltr'>

<table border=3D1 cellpadding=3D0 cellspacing=3D0 valign=3Dtop style=3D'direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title=3D"" summary=3D"">
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7381in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>分期</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.6923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black;
  text-align:center'><span style=3D'font-weight:bold'>治療策略</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7381in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Stage I</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.6923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt'><span
  style=3D'font-weight:bold;color:black'>全子宮 + 雙側卵巢輸卵管切除（TAH + BSO）</span><br>
    - <span style=3D'font-weight:bold;color:black'>IA（低風險）：單獨手術</span><br>
    - <span style=3D'font-weight:bold;color:black'>IB（肌肉層侵犯 &gt;50%）：手術 + 放療</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7381in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Stage II</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>全子宮 + 卵巢輸卵管切除（TAH + BSO）+ 放射治療</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Stage III</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.6729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>全子宮切除 + 放療 + 化療（Cisplatin + Paclitaxel）</span></p>
  </td>
 </tr>
 <tr>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>Stage IV</span></p>
  </td>
  <td style=3D'border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'><span
  style=3D'font-weight:bold'>緩和治療（Palliative therapy），可考慮標靶/免疫治療</span></p>
  </td>
 </tr>
</table>

</div>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:#9BBB59'>補充：</p>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>年輕有生育需求者（低分級
     Type I）</span><span style=3D'font-family:PMingLiU;font-size:11.0pt;
     color:black'>：可考慮</span><span style=3D'font-weight:bold;font-family:PMingLiU;
     font-size:11.0pt;color:black'>高劑量 Progestin 治療 + 定期內膜切片</span></li>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>高危險類型（Serous,
     Clear Cell）</span><span style=3D'font-family:PMingLiU;font-size:11.0pt;
     color:black'>：通常需要</span><span style=3D'font-weight:bold;font-family:PMingLiU;
     font-size:11.0pt;color:black'>手術 + 化療</span></li>
</ul>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:11.0pt;color:black'>&nbsp;</p>

<h2 style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:black'><span
style=3D'font-weight:bold'>預後與高風險因子（Prognosis &amp; High-Risk Factors）</span></h2>

<ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>5年存活率</span><span
     style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>：</span></li>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>Stage I：</span><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>80-90%</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>Stage II：</span><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>70-80%</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>Stage III：</span><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>40-60%</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>Stage IV：</span><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>&lt;20%</span></li>
 </ul>
 <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:#E36C09'>預後不好因子</span><span
     style=3D'font-family:PMingLiU;font-size:11.0pt;color:black'>：</span></li>
 <ul type=3Ddisc style=3D'direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>Type
      II（Serous, Clear Cell）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>淋巴轉移、淋巴血管侵犯（LVI）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>Grade
      III（高分化癌）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>肌肉層侵犯（Myometrial
      Invasion &gt;50%）</span></li>
  <li style=3D'margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style=3D'font-weight:bold;font-family:PMingLiU;font-size:11.0pt;color:black'>p53
      突變</span></li>
 </ul>
</ul>

<p style=3D'margin:0in;font-family:PMingLiU;font-size:16.0pt;color:#1F497D'>&nbsp;</p>

</div>

</div>

</div>

<div>

<p style=3D'margin:0in'>&nbsp;</p>

<p style=3D'text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>
